QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus

OBJECTIVE: 10-year cardiovascular disease (CVD) risk scores are calculated using algorithms, including Framingham (worldwide) and QRISK2 (UK). Recently, an updated QRISK3 model was introduced, which considers new variables including SLE and steroid prescription, not included in QRISK2 and Framingham...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Nicola, Langford-Smith, Alexander W W, Parker, Benjamin J, Bruce, Ian N, Reynolds, John A, Alexander, M Yvonne, McCarthy, Eoghan M, Wilkinson, Fiona L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109811/
https://www.ncbi.nlm.nih.gov/pubmed/30167314
http://dx.doi.org/10.1136/lupus-2018-000272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109811/
https://www.ncbi.nlm.nih.gov/pubmed/30167314
http://dx.doi.org/10.1136/lupus-2018-000272

Ejemplares similares